Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2021006281
Abstract: Key Points • The nonelderly lifetime burden of total medical costs attributable to sickle cell disease was $1.7 million.• Patients incurred $44 000 in out-of-pocket costs due to sickle cell disease over their nonelderly lifetimes. read more here.
Keywords: medical costs; attributable sickle; costs attributable; cell disease ... See more keywords